Who are Silver Colloid's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): The Chlorhexidine gluconate 0.05%, chlorhexidine digluconate, Topical Hydrogen Peroxide, Nanocrystalline silver, Chlorhexidine Gluconate (CHG), Chlorhexidine oral care.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/silver-colloid.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-13 · How we verify

Silver Colloid — Competitive Intelligence Brief

Silver Colloid (Silver Colloid) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Antimicrobial agent. Area: Wound care / Infectious disease.

marketed Antimicrobial agent Wound care / Infectious disease Small molecule Live · refreshed every 30 min

Target snapshot

Silver Colloid (Silver Colloid) — London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's. Silver colloid exerts antimicrobial and anti-inflammatory effects through the release of silver ions that disrupt bacterial cell membranes and reduce inflammatory mediators.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Silver Colloid TARGET	Silver Colloid	London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's	marketed	Antimicrobial agent
The Chlorhexidine gluconate 0.05%	The Chlorhexidine gluconate 0.05%	HaEmek Medical Center, Israel	marketed	Antimicrobial agent / Antiseptic
chlorhexidine digluconate	chlorhexidine digluconate	Universidade Federal do Ceara	marketed	Antimicrobial agent / Antiseptic	Bacterial cell membrane and proteins
Topical Hydrogen Peroxide	Topical Hydrogen Peroxide	University of Toronto	marketed	Antimicrobial agent / Antiseptic
Nanocrystalline silver	Nanocrystalline silver	University of Sorocaba	marketed	Antimicrobial agent
Chlorhexidine Gluconate (CHG)	Chlorhexidine Gluconate (CHG)	University of Pennsylvania	marketed	Antimicrobial agent / Antiseptic
Chlorhexidine oral care	Chlorhexidine oral care	University of Pavia	marketed	Antimicrobial agent / Antiseptic	Bacterial cell membrane and proteins

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Antimicrobial agent class)

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · 1 drug in this class
SIFI SpA · 1 drug in this class
Universidad Miguel Hernandez de Elche · 1 drug in this class
University of Sorocaba · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Silver Colloid — Competitive Intelligence Brief. https://druglandscape.com/ci/silver-colloid. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab